Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. (Q50555807)
Jump to navigation
Jump to search
scientific article published on 5 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. |
scientific article published on 5 November 2010 |
Statements
1 reference
Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. (English)
1 reference
1 reference
Antonio Pellicer
1 reference
Raul Gómez
1 reference
Antonio Abad
1 reference
Francisco Delgado
1 reference
Silvia Tamarit
1 reference
5 November 2010
1 reference
95
1 reference
882-8.e1
1 reference
3
1 reference
Identifiers
1 reference